Tacrolimus Inhalation Powder Gets Orphan Drug Status for Organ Rejection Prophylaxis
The FDA has granted Orphan Drug Designation to Tacrolimus Inhalation Powder (TFF Pharmaceuticals) for prophylaxis of lung allograft rejection.
Transplantation
Pneumocystis Pneumonia Associated With Higher Mortality in Lung Transplants
Patients receiving lung transplants who had pneumocystis pneumonia had higher mortality rates than those without pneumocystis pneumonia.
US Government Proposes New Rules to Increase Organ Transplants
New rules include reimbursing donors for lost wages and tightening standards for organ procurement organizations that collect organs from deceased donors.
Early-Onset Pneumonia in Recipients of Liver Transplant
Early-onset pneumonia with multidrug-resistant organisms is a major concern for patients who have received a liver transplant, and pre- and intra-operative risk factors influence its development, according to study data presented at The American Association for the Study of Liver Diseases’ The Liver Meeting, held November 8 to 12, 2019 in Boston, Massachusetts. In an…
Testing Manufactured Organs on the Recently Deceased Raises Ethical Concerns
Despite increasing numbers of organ donations and optimized organ recovery, the current supply is not sufficient to meet current and future organ needs.
Double Lung Transplant Performed for Vaping-Related Illness
At least 40 deaths linked with vaping-related lung damage have been reported by state health departments.
Sarcoidosis on Associated With Higher Mortality vs COPD, IPF on Transplant List
Patients with sarcoidosis on the lung transplant waiting list had a higher mortality rate than patients with chronic obstructive pulmonary disease or idiopathic pulmonary fibrosis.
Do Patients With Idiopathic PAH Have Worse Lung Transplantation Outcomes?
Patients with idiopathic pulmonary artery hypertension undergoing a lung transplant in which extracorporeal life support is needed experienced poorer outcomes compared with patients with other diagnoses.
Lung and Heart Transplants From HCV-Infected Donors: Expert Roundtable
Further patient advocacy is needed to ensure that recipients of HCV-infected organs have access to direct-acting antivirals as early as possible, including in a prophylactic manner, if data continue to support its benefit.
Lungs From Hepatitis C-Infected Donors Can Be Transplanted Safely
Lung transplant into patients without hepatitis C infection feasible, with excellent function at 6 months.
-
Loading...
-
Loading...
Next post in General Pulmonology
